US 12152027
Heterocyclic compound
granted A61KA61K31/444A61K31/5025
Quick answer
US patent 12152027 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/444, A61K31/5025, A61K9/2018, A61K9/4858